The VICTORION-2 PREVENT study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD). Throughout the study, participants will continue to take their statin alongside either the investigational drug or placebo. For more information, please see the attached: VICTORION-2 PREVENT